Acute Pancreatitis: Study of Possible Etiologies and Risk Factors Affecting Outcome
1 other identifier
observational
300
1 country
1
Brief Summary
This study is to assess the frequency of different etiologies of acute pancreatitis in our locality \& assess the effect of different risk factors on outcome of the patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedAugust 9, 2023
August 1, 2023
4 years
May 21, 2018
August 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The frequency of different etiologies of AP in our locality
At the end of study, total number of patients of each etiology of acute pancreatitis will be calculated as (Gallstones, Alcohol, triglyceridemia, Idiopathic, ERCP,..)
1 year
Secondary Outcomes (4)
Outcome of the patients according to the Atlanta Classification 2012 revision
1 year
Hospital duration of stay
1 year
Rate of transfer to ICU
1 year
Mortality
1 year
Eligibility Criteria
All patients admitted in assuit university hospital during the period of the study and diagnosed as acute pancreatitis
You may qualify if:
- Diagnosis of acute pancreatitis according to the following: the presence of two of the three following criteria:
- abdominal pain consistent with the disease
- serum amylase and or lipase greater than three times the upper limit of normal
- characteristic findings from abdominal imaging Contrast-enhanced computed tomographic (CECT) and or magnetic resonance imaging (MRI) of the pancreas
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmed Mohammed Abu-Elfatth
Asyut, 71515, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ashraf Osman, MD
Assiut University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist of tropical medicine and gastroenterology
Study Record Dates
First Submitted
May 21, 2018
First Posted
July 26, 2018
Study Start
October 1, 2018
Primary Completion
October 1, 2022
Study Completion
October 30, 2022
Last Updated
August 9, 2023
Record last verified: 2023-08